DocuSign (DOCU) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

The e-signature company reported earnings of 86 cents per share, beating forecasts of 85 cents, with revenue coming in at $776 million, $15 million over forecasts for the fourth quarter of fiscal 2025 ...

Learn more about whether Cellebrite DI Ltd. or DocuSign, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Docusign's Q3 results showed unexpected momentum, with revenue and billings growth accelerating, driving shares up ~30% immediately after earnings. I'm downgrading DOCU to a hold rating, as the ...

We posted DOCU earnings live in chat after the close yesterday. Killer quarter, everything moving up, long term thesis intact. Stock price remains weak; likely a poor short term earnings play. But ...